Live Breaking News & Updates on Arrowhead Pharmaceuticals Inc

Stay updated with breaking news from Arrowhead pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Arrowhead Pharmaceuticals Inc. (ARWR) Initiates Phase 1/2a Study of ARO-CFB

Arrowhead Pharmaceuticals Inc. (ARWR) Initiates Phase 1/2a Study of ARO-CFB
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

James Hamilton , Arrowhead Pharmaceuticals Inc , Arrowhead Pharmaceuticals , Translational Medicine ,

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

James Hamilton , Exchange Commission , Arrowhead Pharmaceuticals Inc , Arrowhead Pharmaceuticals , Translational Medicine , Harbor Statement , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports ,

Analysts Set Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) PT at $53.45

Analysts Set Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) PT at $53.45
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Nova Scotia , Kenneth Allen Myszkowski , Christopher Richard Anzalone , Arrowhead Pharmaceuticals Inc , Royal Bank , Jpmorgan Chase Co , Blackrock Inc , Morgan Stanley , Vanguard Group Inc , Arrowhead Pharmaceuticals Price Performance , Analyst Recommendations For Arrowhead Pharmaceuticals , News Ratings For Arrowhead Pharmaceuticals Daily , Arrowhead Pharmaceuticals , Get Free Report , Richard Anzalone , Allen Myszkowski , Street Corp , Get Free , Arrowhead Pharmaceuticals Daily ,

Jefferies Hires Senior JPMorgan Health-Care Banker Philip Ross

Jefferies Hires Senior JPMorgan Health-Care Banker Philip Ross
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United States , Hambrecht Quist , Chris Roop , Philip Ross , Bristol Myers Squibb Co , Merck Co , Alpine Immune Sciences Inc , Arrowhead Pharmaceuticals Inc , Vertex Pharmaceuticals Inc , Bloomberg Jefferies Financial Group Inc , Immunogen Inc , Abbvie Inc , Celgene Corp , Morgan Stanley , Apogee Therapeutics Inc , Jpmorgan Chase Co , Financial Group , Chief Executive Officer Richard Handler , Wall Street , York Based Jefferies , Bristol Myers Squibb , Apogee Therapeutics ,

Plozasiran Reduces Triglycerides, ApoC3 in Phase 2b SHASTA-2 Trial

Plozasiran demonstrates a 74% reduction in triglyceride levels at 24 weeks in patients with severe hypertriglyceridemia in the phase 2b SHASTA-2 trial. ....

Daniel Gaudet , American College Of Cardiology Daniel Gaudet , Arrowhead Pharmaceuticals Inc , American College Of Cardiology , University Of Montreal , Arrowhead Pharmaceuticals , American College , Annual Scientific Sessions , Patients With Severe Hypertriglyceridemia , Annual Scientific , Plozasiran Reduces Triglyceride Levels , Published April ,